×
Alcon Cash on Hand 2019-2024 | ALC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Alcon cash on hand for the quarter ending June 30, 2024 was
$1.372B
, a
107.56% increase
year-over-year.
Alcon cash on hand for 2023 was
$1.094B
, a
11.63% increase
from 2022.
Alcon cash on hand for 2022 was
$0.98B
, a
37.78% decline
from 2021.
Alcon cash on hand for 2021 was
$1.575B
, a
1.16% increase
from 2020.
View More
Alcon Cash on Hand 2019-2024 | ALC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Alcon cash on hand for 2023 was
$1.094B
, a
11.63% increase
from 2022.
Alcon cash on hand for 2022 was
$0.98B
, a
37.78% decline
from 2021.
Alcon cash on hand for 2021 was
$1.575B
, a
1.16% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$233.2B
Intuitive Surgical (ISRG)
$171.7B
IQVIA Holdings (IQV)
$43.7B
IDEXX Laboratories (IDXX)
$42.2B
Edwards Lifesciences (EW)
$40.5B
DexCom (DXCM)
$27.6B
STERIS (STE)
$23.8B
SONOVA HOLDING (SONVY)
$21.2B
Waters (WAT)
$19.5B
Hologic (HOLX)
$19B
Sysmex ADR (SSMXY)
$12.6B
Fresenius Medical Care AG KGaA (FMS)
$12.3B
Teleflex (TFX)
$11.4B
Globus Medical (GMED)
$9.4B
Penumbra (PEN)
$7.3B
Glaukos (GKOS)
$6.7B
Masimo (MASI)
$6.1B
TransMedics (TMDX)
$5.2B
Integer Holdings (ITGR)
$4.2B
PROCEPT BioRobotics (PRCT)
$4.1B
Tandem Diabetes Care (TNDM)
$2.8B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.6B
Inari Medical (NARI)
$2.6B
Elekta AB (EKTAY)
$2.5B
Nihon Kohden (NHNKY)
$2.5B
RxSight (RXST)
$2.1B
Integra LifeSciences Holdings (IART)
$1.3B
Pulse Biosciences (PLSE)
$1.2B
OPKO Health (OPK)
$1.2B